Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis
Kamishima, T.; Kato, M.; Atsumi, T.; Koike, T.; Onodera, Y.; Terae, S.
Clinical and Experimental Rheumatology 31(1): 154
2013
ISSN/ISBN: 0392-856X PMID: 23190694 Document Number: 668865
Document emailed within 1 workday
Related Documents
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Aicher, K.P.; Dupon, J.W.; White, D.L.; Aukerman, S.L.; Moseley, M.E.; Juster, R.; Rosenau, W.; Winkelhake, J.L.; Brasch, R.C. 1990: Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha Cancer Research 50(22): 7376-7381
Nieto González, J.C.; Monteagudo Saez, I.; López-Longo, F.J.; Serrano, B.én.; Mata Martínez, C.; Carreño Pérez, L. 2013: Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α) Clinical and Experimental Rheumatology 31(5): 776-778
Jorgensen, C.; Couret, I.; Canovas, F.; Bologna, C.; Brochier, J.; Reme, T.; Lipsky, P.; Sany, J. 1996: Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1) Clinical and Experimental Immunology 106(1): 20-25
Shahramian, I.; Noori, N.M.; Hashemi, M.; Sharafi, E.; Baghbanian, A. 2013: A study of serum levels of leptin, ghrelin and tumour necrosis factor-alpha in child patients with cyanotic and acyanotic, congenital heart disease JPMA. Journal of the Pakistan Medical Association 63(11): 1332-1337
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413
Vanderveken, O.M.; De Smet, K.; Dogan-Duyar, S.; Desimpelaere, J.; Duval, E.L.I.M.; De Praeter, M.; Van Rompaey, D. 2012: Pott's puffy tumour in a 5-year old boy: the role of ultrasound and contrast-enhanced CT imaging; surgical case report B-Ent 8(2): 127-129
Manish, R.; Tripathy, R.; Das, B.K. 2003: Plasma glucose and tumour necrosis factor-alpha in adult patients with severe falciparum malaria Tropical Medicine and International Health: Tm and Ih 8(2): 125-128
Braczkowski, R.; Zubelewicz, B.; Romanowski, W.; Lissoni, P.; Brivio, F. 1998: Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms Journal of Experimental and Clinical Cancer Research: Cr 17(3): 349-354
Radhakrishnan, V.V.; Sumi, M.G.; Reuben, S.; Mathai, A.; Nair, M.D. 2003: Circulating tumour necrosis factor alpha and soluble TNF receptors in patients with Guillain-Barre syndrome Indian Journal of Medical Research 117: 216-220
Juhl, P.; Thudium, C.S.; Gudmann, N.S.; Karsdal, M.A.; Bay-Jensen, A.-C.; Siebuhr, A.S. 2018: IL-6 receptor inhibition modulates type IIi collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study Clinical and Experimental Rheumatology 36(4): 568-574
Perri, F.; Clemente, R.; Festa, V.; De Ambrosio, C.C.; Quitadamo, M.; Fusillo, M.; Grossi, E.; Andriulli, A. 1999: Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies Italian Journal of Gastroenterology and Hepatology 31(4): 290-294
Braczkowski, R.; Romanawsky, W.; Danikiewicz, A.; Muc-Wierzgon, M.; Błazelonis, A.; Zubelewicz, B. 2001: Decrease of erythropoietin level by human recombinant tumour necrosis factor alpha (hrec TNFalpha) in patients with advanced cancer Journal of Biological Regulators and Homeostatic Agents 15(4): 366-369
Jin, D.; Tie, N.; Liu, J.; Zhao, L.; Hao, D.; Zhao, Y. 2015: Investigation of the risk of hepatitis B virus reactivation in arthritis patients undergoing anti-tumour necrosis factor alpha therapy Zhonghua Nei Ke Za Zhi 54(4): 313-316
Barile, A.; Sabatini, M.; Iannessi, F.; Di Cesare, E.; Splendiani, A.; Calvisi, V.; Masciocchi, C. 2004: Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled La Radiologia Medica 107(4): 356-366
Darabi, K.; Jaiswal, R.; Hostetler, S.; Bechtel, M.; Zirwas, M. 2009: Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate Journal of Drugs in Dermatology: Jdd 8(2): 175-178
McCusker, S.M.; Curran, M.D.; Dynan, K.B.; McCullagh, C.D.; Urquhart, D.D.; Middleton, D.; Patterson, C.C.; McIlroy, S.P.; Passmore, A.P. 2001: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study Lancet 357(9254): 436-439
Chakravarti, A.; Kumaria, R. 2006: Circulating levels of tumour necrosis factor-alpha and interferon-gamma in patients with dengue and dengue haemorrhagic fever during an outbreak Indian Journal of Medical Research 123(1): 25-30